Home
>
National Drug Code (NDC)
>
ISENTRESS
ISENTRESS - 0006-0473-61 - (RALTEGRAVIR)
Drug Information of ISENTRESS
| Product NDC: | 0006-0473 |
| Proprietary Name: | ISENTRESS |
| Non Proprietary Name: | RALTEGRAVIR |
| Active Ingredient(s): | 25 mg/1 & nbsp; RALTEGRAVIR |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET, CHEWABLE |
| Coding System: | National Drug Codes(NDC) |
Labeler Information of ISENTRESS
| Product NDC: | 0006-0473 |
| Labeler Name: | Merck Sharp & Dohme Corp. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA203045 |
| Marketing Category: | NDA |
| Start Marketing Date: | 20111221 |
Package Information of ISENTRESS
| Package NDC: | 0006-0473-61 |
| Package Description: | 60 TABLET, CHEWABLE in 1 BOTTLE (0006-0473-61) |
NDC Information of ISENTRESS
| NDC Code | 0006-0473-61 |
| Proprietary Name | ISENTRESS |
| Package Description | 60 TABLET, CHEWABLE in 1 BOTTLE (0006-0473-61) |
| Product NDC | 0006-0473 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | RALTEGRAVIR |
| Dosage Form Name | TABLET, CHEWABLE |
| Route Name | ORAL |
| Start Marketing Date | 20111221 |
| Marketing Category Name | NDA |
| Labeler Name | Merck Sharp & Dohme Corp. |
| Substance Name | RALTEGRAVIR POTASSIUM |
| Strength Number | 25 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | HIV Integrase Inhibitors [MoA],Human Immunodeficiency Virus Integrase Strand Transfer Inhibitor [EPC] |
